Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 3196 AL 3210

Functional movement disorder comorbidity in Parkinson's disease: Unraveling the web

Kurtis MM, Pareés I.

Parkinsonism Relat Disord. 2021 Jan;82:138-145. doi: 10.1016/j.parkreldis.2020.10.022. Epub 2020 Oct 15.

Alpha-Synuclein in Alcohol Use Disorder, Connections with Parkinson's Disease and Potential Therapeutic Role of 5' Untranslated Region-Directed Small Molecules

Cahill CM, Aleyadeh R, Gao J, Wang C, Rogers JT.

Biomolecules. 2020 Oct 21;10(10):1465. doi: 10.3390/biom10101465.

Stem Cell-Based Therapies for Parkinson Disease

Liu Z, Cheung HH.

Int J Mol Sci. 2020 Oct 29;21(21):8060. doi: 10.3390/ijms21218060.

Acute parkinsonism in patients with systemic lupus erythematosus: a case report and review of the literature

Wantaneeyawong C, Kasitanon N, Kumchana K, Louthrenoo W.

Int J Neurosci. 2022 Sep;132(9):868-873. doi: 10.1080/00207454.2020.1847106. Epub 2020 Nov 29.

Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy

Brendel M, Barthel H, van Eimeren T, Marek K, Beyer L, Song M, Palleis C, Gehmeyr M, Fietzek U, Respondek G, Sauerbeck J, Nitschmann A, Zach C, Hammes J, Barbe MT, Onur O, Jessen F, Saur D, Schroeter ML, Rumpf JJ, Rullmann M, Schildan A, Patt M, Neumaier B, Barret O, Madonia J, Russell DS, Stephens A, Roeber S, Herms J, Bötzel K, Classen J, Bartenstein P, Villemagne V, Levin J, Höglinger GU, Drzezga A, Seibyl J, Sabri O.

JAMA Neurol. 2020 Nov 1;77(11):1408-1419. doi: 10.1001/jamaneurol.2020.2526.

Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease

Picillo M, Phokaewvarangkul O, Poon YY, McIntyre CC, Beylergil SB, Munhoz RP, Kalia SK, Hodaie M, Lozano AM, Fasano A.

Mov Disord. 2021 Mar;36(3):672-680. doi: 10.1002/mds.28382. Epub 2020 Nov 9.

The Need for Digital Health Solutions in Deep Brain Stimulation for Parkinson's Disease in the Time of COVID-19 and Beyond

Rammo R, Gostkowski M, Rasmussen PA, Nagel S, Machado A.

Neuromodulation. 2021 Feb;24(2):331-336. doi: 10.1111/ner.13307. Epub 2020 Nov 10.

Altered ioflupane single-photon emission computed tomography in anti-IgLON5 disease: A new case mimicking probable progressive supranuclear palsy and review of the literature

González-Ávila C, Casado L, Muro García I, Villacieros-Álvarez J, Vivancos J, Quintas S.

Eur J Neurol. 2021 Apr;28(4):1392-1395. doi: 10.1111/ene.14634. Epub 2020 Dec 2.

Seven Solutions for Neuroprotection in Parkinson's Disease

Devos D, Hirsch E, Wyse R.

Mov Disord. 2021 Feb;36(2):306-316. doi: 10.1002/mds.28379. Epub 2020 Nov 13.

[Dopamine and NMDA Receptors in Basal Ganglia Circuits and Their Roles regarding Motor Control and Learning]

Saito N, Sasaoka T.

Brain Nerve. 2020 Nov;72(11):1135-1142. doi: 10.11477/mf.1416201666.

Transitional Care for Young People with Neurological Disorders: A Scoping Review with A Focus on Patients with Movement Disorders

McGovern E, Pringsheim T, Medina A, Cosentino C, Shalash A, Sardar Z, Fung VSC, Kurian MA, Roze E; MDS Task Force on Pediatrics.

Mov Disord. 2021 Jun;36(6):1316-1324. doi: 10.1002/mds.28381. Epub 2020 Nov 17.

[Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders]

Rodríguez-Sanz A, Peña-Llamas E, Alonso-Cánovas A, Alonso-Frech FA, Borrue-Fernández C, Catalán MJ, Fanjul-Arbós S, García-Cobos E, García-Ramos R, García Ruiz-Espiga P, Herreros-Rodríguez J, Kurtis-Urra M, López-Lozano JJ, López-Manzanares L, Martínez-Castrillo JC, Martínez-Fernández R, Mata M, Pérez-Sánchez JR, Posada IJ, Rojo A, Romero-Muñoz JP, Ruiz-Huete C, Sánchez-Alonso MP, Vivancos-Matellano F, En Representación Del Grupo de Trastornos Del Movimiento de la Asociación Madrileña de Neurología ERDGTDMAMN.

Rev Neurol. 2020 Dec 1;71(11):407-420. doi: 10.33588/rn.7111.2020088.

Controversy of TMEM230 Associated with Parkinson's Disease

Wang X, Whelan E, Liu Z, Liu CF, Smith WW.

Neuroscience. 2021 Jan 15;453:280-286. doi: 10.1016/j.neuroscience.2020.11.004. Epub 2020 Nov 17.

The Endoplasmic Reticulum Stress/Unfolded Protein Response and Their Contributions to Parkinson's Disease Physiopathology

Costa CAD, Manaa WE, Duplan E, Checler F.

Cells. 2020 Nov 17;9(11):2495. doi: 10.3390/cells9112495.

Long-Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease

Pagan FL, Wilmarth B, Torres-Yaghi Y, Hebron ML, Mulki S, Ferrante D, Matar S, Ahn J, Moussa C.

Mov Disord. 2021 Mar;36(3):740-749. doi: 10.1002/mds.28389. Epub 2020 Nov 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias